Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Biochim Biophys Acta. 2011 Feb 26;1813(7):1373–1381. doi: 10.1016/j.bbamcr.2011.02.012

Mitochondrial Ca2+ Influx and Efflux rates in Guinea Pig Cardiac Mitochondria: Low and High Affinity Effects of Cyclosporine A

An-Chi Wei 2, Ting Liu 1, Sonia Cortassa 1,2, Raimond L Winslow 2, Brian O’Rourke 1
PMCID: PMC3109245  NIHMSID: NIHMS278362  PMID: 21362444

Abstract

Ca2+ plays a central role in energy supply and demand matching in cardiomyocytes by transmitting changes in excitation-contraction coupling to mitochondrial oxidative phosphorylation. Matrix Ca2+ is controlled primarily by the mitochondrial Ca2+ uniporter (mCU) and the mitochondrial Na+/Ca2+ exchanger (mNCE), influencing NADH production through Ca2+-sensitive dehydrogenases in the Krebs cycle. In addition to the well-accepted role of the Ca2+-triggered mitochondrial permeability transition pore (PTP) in cell death, it has been proposed that the PTP might also contribute to physiological mitochondrial Ca2+ release. Here we selectively measure Ca2+ influx rate through the mCU and Ca2+ efflux rates through Na+-dependent and Na+-independent pathways in isolated guinea pig heart mitochondria in the presence or absence of inhibitors of mNCE (CGP 37157) or the PTP (CsA). CsA suppressed the negative bioenergetic consequences (ΔΨm loss, Ca2+ release, NADH oxidation, swelling) of high extramitochondrial Ca2+ additions, allowing mitochondria to tolerate total mitochondrial Ca2+ loads of >400 nmol/mg protein. For Ca2+ pulses up to 15µM, Na+-independent Ca2+ efflux through the PTP accounted for ~5% of the total Ca2+ efflux rate compared to that mediated by the mNCE (in 5mM Na+). Unexpectedly, we also observed that CsA inhibited mNCE-mediated Ca2+ efflux at higher concentrations (IC50=2µM) than those required to inhibit the PTP, with a maximal inhibition of ~40% at 10µM CsA, while having no effect on the mCU. The results suggest a possible alternative mechanism by which CsA could affect mitochondrial Ca2+ load in cardiomyocytes, potentially explaining the paradoxical toxic effects of CsA at high concentrations.

Keywords: mitochondrial Na+/Ca2+ exchanger, permeability transition pore, mitochondrial calcium uniporter, oxidative phosphorylation, bioenergetics, calcium transport

Introduction

Ca2+ is the central player in excitation-contraction coupling in cardiac myocytes, but it also serves as an important signaling molecule between cytosol and mitochondria. In the heart, mitochondria take up Ca2+ from the cytosol through the calcium uniporter (mCU) and extrude it primarily through the mitochondrial Na+/Ca2+ exchanger (mNCE) [1, 2]. Mitochondrial calcium (Ca2+m) regulates NADH production by activating Ca2+-sensitive dehydrogenases in the TCA cycle [3] and may stimulate oxidative phosphorylation at other sites as well [4, 5]. By changing the driving force for Ca2+ efflux through the mNCE, alterations in cytosolic Na+ (Na+i) will significantly impact the rate of mitochondrial Ca2+ accumulation when the amplitude or frequency of the cytosolic Ca2+ transient changes. For example, Na+i is elevated in chronic heart failure [68] and during ischemia-reperfusion injury [912], as well as during treatment with cardiac glycosides, and we have shown that high Na+i blunts Ca2+m accumulation in cardiac myocytes subjected to a rapid increase in work [1316]. Moreover, the oxidation of NAD(P)H associated with inadequate mitochondrial Ca2+ signalling contributes to increased oxidative stress, arrhythmias and contractile dysfunction [15, 16]. These detrimental effects are prevented by treatment with an mNCE inhibitor, or by lowering Na+i, emphasizing the importance of mitochondrial Ca2+ efflux as a modulator of excitation-contraction-bioenergetic coupling.

Na+-independent mitochondrial Ca2+ efflux can also play a role in mitochondrial Ca2+ regulation, particularly in certain non-cardiac tissues in which a H+/Ca2+ antiporter is active [17]. Alternatively, Gunter and Pfeiffer [18] proposed that the transient and reversible opening of the mitochondrial permeability transition pore (PTP) could be an energetically favorable way to release mitochondrial Ca2+ in a Na+-independent manner, albeit with the proviso that the concomitant loss of mitochondrial membrane potential (ΔΨm) would have to be rapidly reversed in order to maintain ATP production. In this light, Altschuld et al. [19] reported that cyclosporine A (CsA), an inhibitor of the PTP [20, 21], increased mitochondrial Ca2+ load in rat ventricular myocytes, possibly explaining the toxic effects of CsA on electrically-paced rat cardiomyocytes[22]. In a recent study, we too observed enhanced mitochondrial Ca2+ loading in response to pacing in the presence of CsA (see supplemental data Fig. S2 in ref.[14]). These observations could be interpreted as evidence for a physiological role for reversible PTP opening during Ca2+ cycling or that pathophysiological activation of the PTP is occurring in a fraction of mitochondria in the network of the isolated cardiomyocyte. However, based on the behavior of isolated mitochondria, unless there is significant metabolic stress [23, 24], mitochondria should be able to tolerate rather large Ca2+ loads without activation of the PTP because of the robust Ca2+ buffering capacity of the matrix due to the formation of calcium phosphate precipitates [25, 26].

In the context of the outstanding questions mentioned above, and in order to understand mitochondrial Ca2+ handling in both normal and disease states, quantitative measurements of unidirectional Ca2+ uptake and efflux rates are necessary. In this study, Ca2+ fluxes through mCU, mNCE and PTP were measured in normal isolated guinea pig heart mitochondria. The effects of variables such as Ca2+i, Na+i, and CsA on the mitochondrial Ca2+ transport were explored. The results indicate that the steady state extramitochondrial Ca2+ concentration is strongly influenced by Na+i and that, unexpectedly, CsA, at concentrations higher than that required to inhibit the PTP, has an inhibitory effect on both PTP- and mNCE-mediated mitochondrial Ca2+ efflux. These kinetic measurements also provide essential information for refinement of computational models of mitochondrial Ca2+ handling, with the ultimate goal of interpreting the influence of mitochondria on cellular Ca2+ handling, redox potential and energetics.

Methods

Guinea pig heart mitochondria were isolated using a protocol described previously[27]. The extramitochondrial Ca2+ concentration ([Ca2+]out) was measured using the Ca2+-sensitive fluorescent probe, CaGreen-5N, hexapotasssium salt (Molecular Probes, Invitrogen) in a fluorometer (Quantamaster, Photon Technologies International) at room temperature. Mitochondria (~0.5mg) were suspended in a potassium-based buffer solution consisting of: 137mM KCl, 2mM KH2PO4, 20µM EGTA, 20mM HEPES, and 5mM glutamate/malate (G/M) at pH 7.15. Calcium green-5N (0.1µM) fluorescence was recorded at excitation and emission wavelengths of 505nm and 535nm [28]. Mitochondrial 90° light scattering was monitored at 540nm with a second detector and NADH fluorescence was recorded with excitation at 350nm and emission at 450nm. Mitochondrial membrane potential was monitored by the ratiometric method of Scaduto and Grotyohann [29] using tetramethylrhodamine methyl ester (TMRM) at excitations of 546nm and 573nm and emission at 590nm. Mitochondrial protein concentrations were determined by the BCA assay (Thermo Scientific Pierce).

Free calcium in the buffer solution was calculated using MaxChelator (http://www.stanford.edu/~cpatton/maxc.html) and a standard curve was constructed in the presence of mitochondria, but with Ca2+ uptake blocked (see supplemental Figure S1) relating the CaGreen-5N signal to the free Ca2+ concentration in the buffer solution by fitting to the Grynkiewicz equation [30].

[Ca2+]free=Kd[FFminFmaxF]

, where F is the fluorescence intensity of calcium green at the experimental calcium level, Fmin is the fluorescence intensity without calcium, Fmax is the fluorescence intensity of CaGreen-5N saturated with calcium, and the Kd (14µM) was the solution dissociation constant of CaGreen-5N provided by the manufacturer.

To study CsA effects on Ca2+ transport by mitochondria, cyclosporine A (Sigma-Aldrich) was added directly to the mitochondrial suspension from a 4mM dimethyl sulfoxide (DMSO) stock solution. Amounts of DMSO alone, equivalent to those of the largest amount used in a given experiment (usually <1% of total volume), had no effect on the measured parameters.

Statistical Analysis

The results are presented as mean±SEM. An unpaired Student’s t-test was used to evaluate the significance of the differences between means of CsA-treated versus untreated mitochondrial Ca2+ fluxes using either Origin (Microcal) or Matlab statistical toolbox. Statistical significance was assumed at p<0.05.

Results

The capacity of guinea pig heart mitochondria to accumulate Ca2+ was tested by multiple additions of Ca2+ (first addition was 15µM and subsequent ones were 25µM each) while monitoring extramitochondrial Ca2+ concentration ([Ca2+]out), NADH, light scattering and ΔΨm (Fig. 1). The first addition of Ca2+ evoked rapid Ca2+ uptake from the medium and a small (~5mV) depolarization of ΔΨm corresponding to the energetic cost of Ca2+ entry (that is, Ca2+ uptake, coupled to Na+/Ca2+ exchange, coupled to Na+/H+ exchange), a transient oxidation of NADH, and a decrease in light scattering corresponding to an increase in mitochondrial volume (Figs. 1A and 1B). In the absence of CsA, by the third or fourth Ca2+ addition, a secondary release of Ca2+ is evident, and is accompanied by a larger and sustained decrease in ΔΨm and NADH, but the ability of the suspension to regulate extramitochondrial Ca2+ is still partially maintained (Fig. 1A). After the sixth Ca2+ addition, however, corresponding to a total mitochondrial Ca2+ load of more than 400 nmol Ca2+/mg mitochondrial protein, ΔΨm collapses, NADH is oxidized, additional swelling occurs, and Ca2+ is released to the medium (Fig. 1A). In striking contrast, in the presence of CsA (4 µM), the mitochondria readily take up eight additions of Ca2+ while maintaining ΔΨm, NADH, and mitochondrial volume. Steady-state [Ca2+]out was regulated at a constant setpoint (Fig. 1B) with no evidence of a permeability transition.

Figure 1.

Figure 1

Effects of sequential Ca2+ additions on mitochondrial Ca2+ uptake and energetic parameters. Mitochondria were suspended in KCl-based solution with 5mM NaCl and 5mM G/M and the mitochondrial membrane potential (ΔΨm), NADH, volume change(from light scattering) and extra-mitochondrial Ca2+ level were simultaneously monitored. (A) In the absence of cyclosporine A (CsA), the mitochondrial permeability transition pore (PTP) opens after a train of calcium pulses accompanied by mitochondrial swelling, membrane potential depolarization, and efflux of Ca2+ from the mitochondria. The first calcium pulse is 15µM free Ca2+ and each pulse afterward was 25µM. The total free Ca2+ load tolerated before full PTP opening in this experiment was 400nmol/mg. (B) 4µM cyclosporine A augmented mitochondrial calcium uptake capacity by preventing PTP opening. (C) After the Ca2+ addition, multiple pulses of Na+ were added from 5mM to 60mM to examine the effects of increased Na+-dependent efflux on steady state extramitochondrial Ca2+.

Since PTP activation was not a factor for the response to a single addition of Ca2+, we focused on measuring the mitochondrial Ca2+ influx and efflux rates under various conditions for additions of Ca2+ no greater than 20µM. For a single Ca2+ addition of 15µM, in the absence of Na+, mitochondrial Ca2+ uptake was rapid and [Ca2+]out was lowered to < 0.32 µM (Fig. 1C; left panel) in less than 200 sec. The Ca2+ addition had minimal effects on ΔΨm (it decreased by only 2 mV)(Fig. 1C; left panel) and NADH (Fig. 1C; right panel). The effects of sequentially increasing Na+ on steady state [Ca2+]out were then tested. Increasing extramitochondrial Na+ concentration to 5, 10 and 15 mM Na+ increased the [Ca2+]out setpoints to 0.80µM, 1.28µM, and 1.34µM, respectively (Fig. 1C; left panel). For Na+ greater than 15mM, however, [Ca2+]out paradoxically decreased to 1.12µM (30mM) and 0.76µM (60mM), presumably because the capacity of the mitochondria to regulate matrix Na+ through Na+/H+ exchange may have been saturated, thus allowing matrix Na+ levels to rise and decreasing the driving force for Ca2+ extrusion through the mNCE.

Mitochondrial calcium uptake and extrusion in cardiac mitochondria are mediated mainly through mCU and mNCE under normal conditions in the absence of PTP activation[18]. A protocol was developed to study the individual Ca2+ uptake and efflux rates by loading mitochondria with a single 15µM Ca2+ pulse and then selectively blocking mCU with Ru360 (mCU inhibitor)[3133], mNCE with CGP-37157 (CGP)[34] or PTP with CsA[21]. With 5 mM Na+ in the buffer, Ca2+ was added to energized mitochondria pretreated with either CGP (10µM), CsA (10µM), or CGP+CsA. In all cases, mitochondrial Ca2+ uptake was rapid and a steady state representing the balance between Ca2+ uptake and efflux rates was achieved approximately 200 sec after the pulse (Fig. 2; phase i). The steady state [Ca2+]out (CaSS) was modestly decreased by CsA and more significantly lowered by CGP or CGP+CsA (to ~0.5µM). The unidirectional Ca2+ efflux rate was then measured after application of Ru360 (Fig. 2; phase ii). CGP suppressed the majority of the Ca2+ efflux in 5mM Na+ (Fig. 2; blue trace). Interestingly, in addition to blocking the remaining small CGP-insensitive Ca2+ efflux (CGP+CsA; Fig. 2: green trace), CsA also inhibited a significant fraction of total Ca2+ efflux (Fig. 2; red trace), prompting further investigation of its effects.

Figure 2.

Figure 2

Selective block of mCU following a Ca2+ addition with Ca2+ uptake and efflux active. Phase (i): in the presence of 5mM NaCl and 5mM G/M, a 15µM Ca2+ pulse was given and there is a net uptake of Ca2+. A steady state extramitochondrial Ca2+ concentration is attained when the Ca2+ influx and efflux rates are equal. Phase (ii): after the addition of Ru360, influx through the mCU is blocked and net Ca2+ efflux occurs via the Na+-dependent pathway (mNCE) and the Na+-independent pathway (PTP). CsA partially inhibited efflux, which was mainly contributed by the mNCE, as indicated by it’s CGP-37157 sensitivity. Inhibitor concentrations: 5nM Ru360, 10µM CsA, and 10µM CGP.

The Na+ dependence of CaSS and the Ca2+ efflux rate in the presence and absence of CsA was analyzed by varying Na+ in the buffer from 0 to 60mM (Fig. 3A). Several parameters were measured for this protocol (Fig. 3B): the initial Ca2+ uptake rate (rate 1; Fig. 3C) after the addition of Ca2+; the net Ca2+ extrusion rate after Ru360 addition (rate 2; Fig. 3D); and the CaSS (at the end of phase i; Fig 3E). The average mitochondrial Ca2+ load after a single Ca2+ addition (15µM) was calculated as the total amount of Ca2+ added to the cuvette minus CaSS, normalized to the mitochondrial protein concentration (Fig. 3F).

Figure 3.

Figure 3

Effects of extramitochondrial Na+ on net Ca2+ uptake and extrusion. (A) Superimposed traces of [Ca2+]out with the experimental protocol shown in Figure 2. Isolated mitochondria were equilibrated in buffer solutions containing 0 to 60mM Na+, with or without 10µM CsA. (B) Mitochondrial parameter measurements: Ca2+ uptake slope at 130 to 140sec (rate1), Ca2+ efflux slope at 380 to 390sec (rate2), steady state extramitochondrial Ca2+ at 350sec (CaSS). (C–E) Na+ effects on rate1, rate2 and CaSS. (F) The mitochondria Ca2+ load calculated from the difference between the Ca2+ added and the CaSS. Data presented as mean±SEM, n=3. * P<0.05, (−)CsA vs (+)CsA. Filled symbols: control data, Open symbols: CsA (10µM) treatment.

CaSS (Fig. 3E) increased from 0.6µM to 2µM as extra-mitochondrial Na+ concentration increased from 5mM to 15mM by increasing net Ca2+ extrusion (Fig. 3D) and reducing mitochondria Ca2+ load (Fig. 3F). When [Na+]out was higher than 30mM, Na+ had the opposite effect and mitochondrial Ca2+ load increased (i.e., CaSS decreased). CsA (10µM) also decreased CaSS (Fig. 3E) and increased Ca2+ load in the mitochondria (Fig. 3F). The net unidirectional Ca2+ efflux rate was significantly reduced by CsA (Fig. 3D) but there was no effect of CsA on the Ca2+ uptake rate (Fig. 3C).

A second protocol was employed to more selectively measure individual fluxes from mCU, mNCE and PTP (Fig. 4A). A single Ca2+ addition was made under zero-Na+ conditions and then Ru360 was added to block the mCU, leaving active only the Na+-independent Ca2+ efflux pathway [35]. Na+ was then added to activate mNCE [17, 36]. The maximum uptake rate of mCU measured in guinea pig heart mitochondria with a 15µM free Ca2+ addition was 0.49±0.04 nmol/mg/sec (Fig. 4B). The Na+-independent Ca2+ extrusion rate was 0.003±0.0004 nmol/mg/sec and the Na+-dependent (plus Na+-independent) extrusion rate with 5mM Na+ was 0.018±0.003 nmol/mg/sec (Fig. 4B). CsA (10µM) reduced Na+-independent Ca2+ efflux measured in phase ii from 0.003 to 0.001 nmol/mg/sec, consistent with a small Ca2+ leak mediated by the PTP [37, 38]. However, in the presence of CsA, a 40% inhibition of the Na+-dependent Ca2+ efflux measured in phase iii, was also observed (CsA decreased the Na+-dependent efflux rate to 0.011±0.001 nmol/mg/sec; Fig, 4B).

Figure 4.

Figure 4

Unidirectional Ca2+ flux rates through the mCU, PTP, and mNCE (A) A single Ca2+ pulse (15µM) is given in 0mM Na+ solution (i: mCU-mediated Ca2+ uptake) and then Ru360 (5nM) is added to block the Ca2+ uptake pathway, leaving only Na+-independent Ca2+ extrusion (ii: includes PTP-mediated leak). 5mM Na+ is then added to activate Na+-dependent Ca2+ extrusion (iii: mNCE). (B) Summary data for mitochondrial Ca2+ transport rates in the presence and absence of 10µM CsA. Data presented as mean±SEM, n=11. *P<0.05. (C) Ca2+ dependence of the Ca2+ influx and efflux rates for Ca2+ additions between 2 and 20µM using the same protocol. Data presented as mean±SEM, n=5. (D) Na+-dependence of the initial mNCE rate with additions of different concentrations of Na+ (2.5mM to 60mM). Data presented as mean±SEM, n=5. Filled symbols: control data, Open symbols: CsA (10µM) treatment.

The dependence of the Ca2+ transport rates on the size of the extramitochondrial Ca2+ addition ([Ca2+]added), ranging from 2µM to 20µM, using the second protocol was determined (Fig. 4C). The maximal Ca2+ uptake rate increased linearly as a function of [Ca2+]added from 0.05nmol/sec/mg to 0.6nmol/sec/mg and was not significantly altered by CsA. The mNCE flux (with 5mM NaCl) also increased from ~0.015 to 0.03 nmol/sec/mg as [Ca2+]added was increased (Fig. 4C), corresponding to mitochondrial Ca2+ loads after the Ca2+ uptake phase of 4.5, 19, 37, 57, and 77 nmol/mg for [Ca2+]added levels of 2, 5, 10, 15, and 20µM, respectively. In the presence of 10µM CsA, the mNCE rate was approximately 0.012 nmol/sec/mg and, interestingly, this rate did not increase as a function of [Ca2+]added (Fig. 4C). The Na+-independent Ca2+ efflux was minimally increased by raising [Ca2+]added over the range of 2–15µM (from 0.001 to 0.002 nmol/mg/sec), but a larger CsA-sensitive Na+-independent Ca2+ efflux (0.006nmol/mg/sec) was evoked after a 20µM Ca2+ addition (Fig, 4C).

The effects of Na+, in the range of 2.5mM to 60mM (covering both the physiological and pathophysiological range of Na+i [14, 16, 39]), on the mNCE rate (phase iii) were investigated after Ca2+ loading with 15µM Ca2+ (Fig. 4D). The mNCE rate increased from 0.01 nmol/mg/sec to 0.07 nmol/mg/sec as [Na+]out increased from 2.5mM to 15mM then decreased at higher [Na+]out from 30mM to 60mM. Again, CsA partially inhibited mNCE flux, reducing the rates by about 0.01nmol/mg/sec over the full range of [Na+]out.

The instantaneous mCU rate as a function of [Ca2+]out could also be determined during active mitochondrial Ca2+ uptake from single Ca2+ additions (Fig. 5). A relationship similar to that determined above from the maximal Ca2+ uptake rates for various Ca2+ additions (Fig 4C) was obtained.

Figure 5.

Figure 5

Instantaneous relationship between mCU-mediated Ca2+ influx rate dCa2+/dt and extramitochondrial Ca2+.

The concentration dependence of the CsA inhibition of Ca2+ efflux was investigated for a range of [CsA] from 0.05µM to 40µM (Fig. 6). Maximal inhibition of mNCE flux (15µM Ca2+ loading pulse; 5mM Na+ addition) by CsA was 40% (reduced from 0.020 nmol/mg/sec to 0.012 nmol/mg/sec) for [CsA] ≥10µM (10–40µM range equivalent to 40 to 160nmol CsA/mg). The half-maximal inhibitory concentration (IC50) for inhibition of the mNCE by CsA was 2µM. Inhibition of the Na+-independent Ca2+ efflux, presumably mediated by the PTP, was maximal at a lower CsA concentration (0.05µM; 200pmol/mg), which corresponds to the effective inhibitory concentration of CsA for the PTP reported previously [20, 21, 40].

Figure 6.

Figure 6

Concentration-dependence of CsA inhibition of PTP- or mNCE-mediated Ca2+ efflux (left panel). Lack of effect of CsA on mCU rate (right panel). Mitochondria were incubated with different concentrations of cyclosporine A (0, 0.05, 2, 10, 20, 40µM) in a KCl-based buffer solution with 5mM G/M. Mitochondria then were given a 15µM Ca2+ loading pulse and a 5mM Na+ addition after a Ru360 addition. Data presented as mean±SEM, n=5~6.

Discussion

The present work provides the first quantitative measurements of the unidirectional Ca2+ uptake and extrusion rates of mitochondria from the guinea pig heart and analyzes the influence of [Ca2+]out, [Na+]out, CsA, CGP-37157 and Ru360 on Ca2+ transport. Maximal Ca2+ uptake rates through the Ru360-sensitive mCU for Ca2+ additions of 2 to 20µM ranged from 0.05 to 0.6 nmol/sec/mg and the steady-state extramitochondrial Ca2+ level was dependent on concomitant Ca2+ efflux, primarily through the mNCE. Both Na+-independent and Na+-dependent Ca2+ efflux pathways were present, with the mNCE rate predominating (roughly 10-fold higher than the Na+-independent rate). The mNCE had a biphasic dependence on Na+; its rate increasing over the range of 2.5 to 15mM and then decreasing at 30–60mM. In addition to preventing PTP activation for large mitochondrial Ca2+ loads exceeding 400 nmoles/mg, CsA increased the mitochondrial Ca2+ load for single lower Ca2+ pulses by inhibiting the Na+-independent Ca2+ efflux pathway with high affinity (pmol/mg range) and partially inhibiting Na+-dependent Ca2+ efflux with a lower affinity (~2µM IC50; nmol/mg range).

Mitochondrial Ca2+ transport in the heart is a topic of increasing interest and frequent controversy [4143]. In terms of physiological regulation, Ca2+ uptake during EC coupling provides a crucial feedforward signal to mitochondrial oxidative phosphorylation to increase NADH production and ATP supply to meet the demands of contractile activation and ion transport. On the other hand, excessive mitochondrial Ca2+ loading, by activating the PTP, is a key event leading to necrotic or apoptotic cell death [24, 44]. Understanding the balance between the positive and negative effects of mitochondrial Ca2+ requires a detailed understanding of the factors modulating the Ca2+ uptake and efflux pathways under normal and pathophysiological conditions. Early work by Chance [5] showed that Ca2+ additions to mitochondria evoked rapid (<100 msec) changes in the redox potential of the respiratory chain carrier cytochrome b and transient oxidation followed by reduction of the pyridine nucleotide (NADH) pool, as well as transient stimulation of mitochondrial respiration. A decrease in light scattering (mitochondrial swelling) was also observed upon Ca2+ addition, and when multiple Ca2+ additions were made, a threshold was reached at which NADH completely oxidized and swelling was maximal. These early observations of large amplitude mitochondrial swelling are quite similar to what is observed using the “standard” PTP assay, as shown in Figure 1 for multiple Ca2+ additions. Notably, the CsA-inhibitable Ca2+ release and reuptake evident after the third, fourth, and fifth Ca2+ additions in Figure 1A are followed by a complete release of Ca2+ from the mitochondrial matrix after the sixth addition (total Ca2+ added was 140µM, or 400 nmoles/mg protein), which also corresponded to the collapse of ΔΨm, NADH oxidation, and large amplitude swelling. Prior to the sustained activation of the PTP, the CsA-sensitive partial release and reuptake of Ca2+ could be interpreted in several ways. First, the response could be due to a reversible or transient opening of the PTP, which has been previously proposed [37]. Alternatively, the transient Ca2+ release could represent irreversible opening of the PTP in a fraction of the mitochondrial population and reuptake of Ca2+ by the remaining intact mitochondria. Third, a combination of the two effects could be occurring, i.e., Ca2+ release from mitochondria in which the PTP is open, followed by PTP closure as their Ca2+ load is decreased [45]. Arguing against the idea that the PTP opening is reversed is the observation that depolarization of ΔΨm and oxidation of the NADH pool is sustained even after the released Ca2+ is taken back up, supporting the interpretation that a fraction of the mitochondria have undergone irreversible PTP activation. Interestingly, in the presence of CsA, the initial swelling evoked by Ca2+ is almost completely reversed in a stepwise manner by subsequent Ca2+ additions, indicating that some type of Ca2+-mediated volume regulation has been activated (see light scattering recording in Fig. 1B). Further investigation will be required to characterize the mechanism responsible for this effect.

For smaller single Ca2+ additions ≤15µM, corresponding to mitochondrial Ca2+ loads of 57 nmol/mg, PTP activation was not a significant factor, and the maximal Ca2+ uptake rate in the absence of Na+ was not altered by CsA. This indicates that we were truly measuring the unidirectional flux through the mCU, which was completely inhibited by Ru360. The Ca2+ uptake rates that we measured were ~10-fold higher than the Na+-dependent Ca2+ efflux rate, and were similar in magnitude to, but slightly higher than, those reported previously in guinea pig heart mitochondria under less selective conditions [46]. The relatively low affinity of the mCU for Ca2+ (10’s of µM[46]) relative to the range of diastolic (0.1µM) and systolic (1µM) [Ca2+] evident during the cytosolic transient has always raised the question of the relevance of mitochondrial Ca2+ uptake in the beat-to-beat regulation of Ca2+[43]. Nevertheless, there is strong evidence that the close juxtaposition of mitochondria and the sites of SR Ca2+ release (as close as 37nm [47]) creates a local Ca2+ microdomain that could support significant Ca2+ uptake by the mitochondria surrounding the diad[13, 48, 49]. Computational studies of the local Ca2+ in the dyadic cleft during EC coupling indicate that, at the peak of triggered SR Ca2+ release, [Ca2+] at the center of the cleft may approach 600µM, while 200nm away at the periphery of the cleft [Ca2+] may be as high as 100µM, declining back to the diastolic level over 150ms [50]. This would certainly be sufficient to support fast Ca2+ uptake through the mCU, although other cytosolic factors, such as Mg2+,[36, 51], adenine nucleotides [52], or endogenous polyamines [53] could shift the apparent Km for Ca2+ uptake (see supplemental Fig. S3 for uptake rates in the presence of MgATP). The kinetic data obtained in the present work will be vital for refining such models of local Ca2+ transport to include mitochondria near the junctional microdomain.

The effect of extramitochondrial Na+ on the rate of Ca2+ efflux through the mNCE was shown to be biphasic, increasing for Na+ up to 15mM and then decreasing for Na+ in the range of 30–60mM. The latter was true in the experiments where both influx and efflux were active, in which case the extramitochondrial Ca2+ setpoint was affected (Fig. 1C and Fig. 3), or when only Ca2+ efflux was active (Fig. 4D). The steady state [Ca2+]out levels varied from 1 to 2µM as [Na+]out was increased from 5mM to 15mM and then decreased to ~1.25µM at 60mM [Na+]out. The suppressive effect on Ca2+ efflux at higher Na+ was not due to generalized degradation of energetic functions, since ΔΨm, NADH, and volume were not significantly altered (Fig. 1C and 1D). We hypothesize that the suppression of the rate at Na+ > 30mM may be due to Na+ loading of the mitochondrial matrix, which would decrease the driving force for Ca2+ extrusion. This could occur if Na+ influx exceeds the capacity of the proton pumps to support Na+ extrusion coupled to Na+/H+ exchange. A sigmoidal fit of the mNCE rates as Na+ was varied over the range of 5–30 mM yielded a Km for Na+ of 7.5 mM, close to the previously reported value of 8mM obtained for mNCE protein reconstituted in lipid vesicles[54].

The normal range of Na+i reported in unstimulated guinea pig cardiomyocytes is 5–8mM and it increases to 15–20 mM in heart failure [14]; therefore, based on the present findings, approximately a 4-fold increase in the mitochondrial Ca2+ efflux rate would be expected. Consistent with this effect, we have previously reported that elevated Na+i (15mM) accelerates the decay rate and amplitude of mitochondrial Ca2+ transients and decreases the overall mitochondrial Ca2+ loading during a train of electrically-evoked Ca2+ transients in intact guinea pig myocytes - this results in insufficient activation of NADH production to compensate for increased energy demand [13]. A similar impairment of energy supply and demand exists during the development of chronic heart failure [14], or after inhibition of the sarcolemmal Na+ pump with the cardiac glycoside ouabain, which also elevates Na+i to greater than 15mM [16]. During the course of these earlier studies, we also noted that mitochondrial Ca2+ accumulation during a train of Ca2+ transients was moderately potentiated by CsA (see supplementary Fig. S2 in ref [14]), which motivated the present investigation of the effects of CsA on unidirectional mitochondrial Ca2+ influx and efflux rates.

For a single Ca2+ addition, CsA decreased steady state extramitochondrial Ca2+, indicative of an increase in mitochondria Ca2+ accumulation. Hence, we examined whether CsA influenced mCU-mediated Ca2+ influx, Na+-independent Ca2+ efflux, and Na+-dependent Ca2+ efflux. The maximal Ca2+ uptake rate through the mCU was not affected by CsA (up to 10µM). The rate of Na+-independent Ca2+ efflux was less than 5% of the Na+-dependent flux for Ca2+ additions up to 15µM and this pathway was inhibited by just 50nM CsA. This suggests that there may be some small role for PTP opening as a Ca2+ efflux pathway under “normal” conditions; however, one would also expect that other factors present in the cytoplasm, such as ATP[55], would further suppress this residual activation of the PTP. The larger effect of CsA on Ca2+ flux, in the absence of PTP activation, was to inhibit the Na+-dependent Ca2+ efflux rate, with an IC50 of 2µM. Alterations in the energy state of the mitochondria by CsA could not account for this effect, as no significant differences in ΔΨm, NADH, or volume were observed in the presence of CsA. The possibility that CsA could have been acting by suppressing a Na+-dependent potentiation of PTP opening could also be ruled out, based on the observation that all of the Na+-dependent Ca2+ efflux could be blocked by the mNCE inhibitor 1µM CGP 37157, which has an IC50 of approximately 0.36uM[34]. Thus, we conclude that the inhibitory effect of CsA on Na+-dependent mitochondrial Ca2+ efflux was due to inhibition of the mNCE. The nature of this inhibition is presently unknown, but it does not appear to be a direct competitive effect of CsA on the transport site, since the fractional inhbition of mNCE by CsA decreased at higher concentrations of Na+. A kinetic analysis of the data shows that the CsA effect is consistent with a “mixed type” inhibition (see Fig. S2). Notably, the CsA inhibition of Na+-dependent Ca2+ efflux was larger in the presence of higher mitochondrial Ca2+ loads (Fig. 4C), which might indicate that CsA is interfering with an intramitochondrial mNCE regulatory process. By analogy with the sarcolemmal NCX, CsA could be inhibiting internal Ca2+ activation of the transporter (this occurs via a distinct module in the intracellular regulatory loop of the sarcolemmal NCX). Alternatively, there may be multiple isoforms of mNCE present, one of which is activated at higher mitochondrial Ca2+ loads and is inhibited by CsA, with the other forms insensitive to CsA inhibition. These speculative hypotheses can be tested in future studies, aided by the recent discovery of a molecular candidate for mNCE (NCLX)[56].

While the kinetics of mitochondrial Ca2+ fluxes for the mCU, mNCE, and PTP have been previously been characterized in mitochondria from various tissues and species [2, 32, 35, 36, 54, 5658], a systemic and quantitative assessment of the unidirectional influx and efflux rates obtained under identical conditions is required to improve our understanding of mitochondrial Ca2+ transport as a whole. These data will therefore be invaluable for integrated model development in the future. From the perspective of pathophysiology, there is an emerging view that inhibition of PTP opening protects against acute ischemic injury [24, 59], as well as progressive degenerative diseases such as muscular dystrophy [60, 61] and Alzheimer’s [62]. The present findings showing an additional effect of CsA on mNCE suggest that high concentrations of CsA can influence mitochondrial Ca2+ dynamics by a PTP-independent mechanism. Inhibition of mNCE could be beneficial in instances where impaired mitochondrial Ca2+ loading is a problem, such as in heart failure [14, 15]; however, increased mitochondrial Ca2+ loading could also have toxic effects, such as those reported by Olbrich et al [22] for CsA concentrations ranging from 2–8µM in electrically-paced rat cardiomyocytes. In addition, previous studies of the concentration dependence of CsA-mediated effects on ischemia-reperfusion injury indicated that 0.2µM CsA, but not 2µM CsA, was protective [63]. Thus, increased mitochondrial Ca2+ loading could potentially contribute to detrimental effects of CsA at concentrations above that required to inhibit the PTP. Further studies will be required to examine the mechanism of the CsA effect on mNCE and whether it requires the presence of cyclophilin D, as does PTP inhibition [64].

Supplementary Material

01

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Gunter TE, Buntinas L, Sparagna G, Eliseev R, Gunter K. Mitochondrial calcium transport: mechanisms and functions. Cell Calcium. 2000;28:285–296. doi: 10.1054/ceca.2000.0168. [DOI] [PubMed] [Google Scholar]
  • 2.Gunter TE, Sheu SS. Characteristics and possible functions of mitochondrial Ca(2+) transport mechanisms. Biochim Biophys Acta. 2009;1787:1291–1308. doi: 10.1016/j.bbabio.2008.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Denton RM, McCormack JG. Ca2+ as a second messenger within mitochondria of the heart and other tissues. Annu Rev Physiol. 1990;52:451–466. doi: 10.1146/annurev.ph.52.030190.002315. [DOI] [PubMed] [Google Scholar]
  • 4.Territo PR, French SA, Dunleavy MC, Evans FJ, Balaban RS. Calcium activation of heart mitochondrial oxidative phosphorylation: rapid kinetics of mVO2, NADH, AND light scattering. J Biol Chem. 2001;276:2586–2599. doi: 10.1074/jbc.M002923200. [DOI] [PubMed] [Google Scholar]
  • 5.Chance B. The Energy-Linked Reaction of Calcium with Mitochondria. J Biol Chem. 1965;240:2729–2748. [PubMed] [Google Scholar]
  • 6.Despa S, Islam MA, Weber CR, Pogwizd SM, Bers DM. Intracellular Na(+) concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation. 2002;105:2543–2548. doi: 10.1161/01.cir.0000016701.85760.97. [DOI] [PubMed] [Google Scholar]
  • 7.Pogwizd SM, Sipido KR, Verdonck F, Bers DM. Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis. Cardiovasc Res. 2003;57:887–896. doi: 10.1016/s0008-6363(02)00735-6. [DOI] [PubMed] [Google Scholar]
  • 8.Pieske B, Maier LS, Piacentino V, 3rd, Weisser J, Hasenfuss G, Houser S. Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation. 2002;106:447–453. doi: 10.1161/01.cir.0000023042.50192.f4. [DOI] [PubMed] [Google Scholar]
  • 9.Anderson SE, Murphy E, Steenbergen C, London RE, Cala PM. Na-H exchange in myocardium: effects of hypoxia and acidification on Na and Ca. Am J Physiol. 1990;259:C940–C948. doi: 10.1152/ajpcell.1990.259.6.C940. [DOI] [PubMed] [Google Scholar]
  • 10.Pike MM, Kitakaze M, Marban E. 23Na-NMR measurements of intracellular sodium in intact perfused ferret hearts during ischemia and reperfusion. Am J Physiol. 1990;259:H1767–H1773. doi: 10.1152/ajpheart.1990.259.6.H1767. [DOI] [PubMed] [Google Scholar]
  • 11.Anderson SE, Cala PM, Steenbergen C, London RE, Murphy E. Effects of hypoxia and acidification on myocardial Na and Ca. Role of Na-H and Na-Ca exchange. Ann N Y Acad Sci. 1991;639:453–455. doi: 10.1111/j.1749-6632.1991.tb17332.x. [DOI] [PubMed] [Google Scholar]
  • 12.Karmazyn M. The myocardial sodium-hydrogen exchanger (NHE) and its role in mediating ischemic and reperfusion injury. Keio J Med. 1998;47:65–72. doi: 10.2302/kjm.47.65. [DOI] [PubMed] [Google Scholar]
  • 13.Maack C, Cortassa S, Aon MA, Ganesan AN, Liu T, O'Rourke B. Elevated cytosolic Na+ decreases mitochondrial Ca2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes. Circ Res. 2006;99:172–182. doi: 10.1161/01.RES.0000232546.92777.05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Liu T, O'Rourke B. Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching. Circ Res. 2008;103:279–288. doi: 10.1161/CIRCRESAHA.108.175919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kohlhaas M, Liu T, Knopp A, Zeller T, Ong MF, Bohm M, O'Rourke B, Maack C. Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation. 2010;121:1606–1613. doi: 10.1161/CIRCULATIONAHA.109.914911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Liu T, Brown DA, O’Rourke B. Role of Mitochondrial Dysfunction in Cardiac Glycoside Toxicity. J Mol Cell Cardiol. 2010;49(5):728–736. doi: 10.1016/j.yjmcc.2010.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Crompton M, Moser R, Ludi H, Carafoli E. The interrelations between the transport of sodium and calcium in mitochondria of various mammalian tissues. Eur J Biochem. 1978;82:25–31. doi: 10.1111/j.1432-1033.1978.tb11993.x. [DOI] [PubMed] [Google Scholar]
  • 18.Gunter TE, Pfeiffer DR. Mechanisms by which mitochondria transport calcium. Am J Physiol. 1990;258:C755–C786. doi: 10.1152/ajpcell.1990.258.5.C755. [DOI] [PubMed] [Google Scholar]
  • 19.Altschuld RA, Hohl CM, Castillo LC, Garleb AA, Starling RC, Brierley GP. Cyclosporin inhibits mitochondrial calcium efflux in isolated adult rat ventricular cardiomyocytes. Am J Physiol. 1992;262:H1699–H1704. doi: 10.1152/ajpheart.1992.262.6.H1699. [DOI] [PubMed] [Google Scholar]
  • 20.Broekemeier KM, Dempsey ME, Pfeiffer DR. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem. 1989;264:7826–7830. [PubMed] [Google Scholar]
  • 21.Crompton M, Ellinger H, Costi A. Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J. 1988;255:357–360. [PMC free article] [PubMed] [Google Scholar]
  • 22.Olbrich HG, Geerts H, Waldmann U, Mutschler E, Ver Donck L, Kober G, Kaltenbach M. The effect of cyclosporine on electrically paced isolated rat cardiomyocytes. Transplantation. 1991;51:972–976. doi: 10.1097/00007890-199105000-00008. [DOI] [PubMed] [Google Scholar]
  • 23.Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res. 2003;93:292–301. doi: 10.1161/01.RES.0000087542.26971.D4. [DOI] [PubMed] [Google Scholar]
  • 24.Halestrap AP, Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta. 2009;1787:1402–1415. doi: 10.1016/j.bbabio.2008.12.017. [DOI] [PubMed] [Google Scholar]
  • 25.Chalmers S, Nicholls DG. The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria. J Biol Chem. 2003;278:19062–19070. doi: 10.1074/jbc.M212661200. [DOI] [PubMed] [Google Scholar]
  • 26.Nicholls DG, Chalmers S. The integration of mitochondrial calcium transport and storage. J Bioenerg Biomembr. 2004;36:277–281. doi: 10.1023/B:JOBB.0000041753.52832.f3. [DOI] [PubMed] [Google Scholar]
  • 27.Aon MA, Cortassa S, Wei AC, Grunnet M, O'Rourke B. Energetic performance is improved by specific activation of K+ fluxes through K(Ca) channels in heart mitochondria. Biochim Biophys Acta. 2010;1797:71–80. doi: 10.1016/j.bbabio.2009.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci U S A. 1996;93:9893–9898. doi: 10.1073/pnas.93.18.9893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Scaduto RC, Jr, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J. 1999;76:469–477. doi: 10.1016/S0006-3495(99)77214-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440–3450. [PubMed] [Google Scholar]
  • 31.Matlib MA, Zhou Z, Knight S, Ahmed S, Choi KM, Krause-Bauer J, Phillips R, Altschuld R, Katsube Y, Sperelakis N, Bers DM. Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J Biol Chem. 1998;273:10223–10231. doi: 10.1074/jbc.273.17.10223. [DOI] [PubMed] [Google Scholar]
  • 32.Kirichok Y, Krapivinsky G, Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature. 2004;427:360–364. doi: 10.1038/nature02246. [DOI] [PubMed] [Google Scholar]
  • 33.Ying WL, Emerson J, Clarke MJ, Sanadi DR. Inhibition of mitochondrial calcium ion transport by an oxo-bridged dinuclear ruthenium ammine complex. Biochemistry. 1991;30:4949–4952. doi: 10.1021/bi00234a016. [DOI] [PubMed] [Google Scholar]
  • 34.Cox DA, Conforti L, Sperelakis N, Matlib MA. Selectivity of inhibition of Na(+)-Ca2+ exchange of heart mitochondria by benzothiazepine CGP-37157. J Cardiovasc Pharmacol. 1993;21:595–599. doi: 10.1097/00005344-199304000-00013. [DOI] [PubMed] [Google Scholar]
  • 35.Wingrove DE, Gunter TE. Kinetics of mitochondrial calcium transport. I. Characteristics of the sodium-independent calcium efflux mechanism of liver mitochondria. J Biol Chem. 1986;261:15159–15165. [PubMed] [Google Scholar]
  • 36.Wingrove DE, Gunter TE. Kinetics of mitochondrial calcium transport. II. A kinetic description of the sodium-dependent calcium efflux mechanism of liver mitochondria and inhibition by ruthenium red and by tetraphenylphosphonium. J Biol Chem. 1986;261:15166–15171. [PubMed] [Google Scholar]
  • 37.Ichas F, Jouaville LS, Mazat JP. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell. 1997;89:1145–1153. doi: 10.1016/s0092-8674(00)80301-3. [DOI] [PubMed] [Google Scholar]
  • 38.Ichas F, Mazat JP. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim Biophys Acta. 1998;1366:33–50. doi: 10.1016/s0005-2728(98)00119-4. [DOI] [PubMed] [Google Scholar]
  • 39.Murphy E, Eisner DA. Regulation of intracellular and mitochondrial sodium in health and disease. Circ Res. 2009;104:292–303. doi: 10.1161/CIRCRESAHA.108.189050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Halestrap AP, Davidson AM. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J. 1990;268:153–160. doi: 10.1042/bj2680153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Maack C, O'Rourke B. Excitation-contraction coupling and mitochondrial energetics. Basic Res Cardiol. 2007;102:369–392. doi: 10.1007/s00395-007-0666-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.O'Rourke B, Blatter LA. Mitochondrial Ca2+ uptake: tortoise or hare? J Mol Cell Cardiol. 2009;46:767–774. doi: 10.1016/j.yjmcc.2008.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Huser J, Blatter LA, Sheu SS. Mitochondrial calcium in heart cells: beat-to-beat oscillations or slow integration of cytosolic transients? J Bioenerg Biomembr. 2000;32:27–33. doi: 10.1023/a:1005556227425. [DOI] [PubMed] [Google Scholar]
  • 44.Di Lisa F, Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res. 2006;70:191–199. doi: 10.1016/j.cardiores.2006.01.016. [DOI] [PubMed] [Google Scholar]
  • 45.Novgorodov SA, Gudz TI, Kushnareva YE, Zorov DB, Kudrjashov YB. Effect of cyclosporine A and oligomycin on non-specific permeability of the inner mitochondrial membrane. FEBS Lett. 1990;270:108–110. doi: 10.1016/0014-5793(90)81245-j. [DOI] [PubMed] [Google Scholar]
  • 46.Scarpa A, Graziotti P. Mechanisms for intracellular calcium regulation in heart. I. Stopped-flow measurements of Ca++ uptake by cardiac mitochondria. J Gen Physiol. 1973;62:756–772. doi: 10.1085/jgp.62.6.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sharma VK, Ramesh V, Franzini-Armstrong C, Sheu SS. Transport of Ca2+ from sarcoplasmic reticulum to mitochondria in rat ventricular myocytes. J Bioenerg Biomembr. 2000;32:97–104. doi: 10.1023/a:1005520714221. [DOI] [PubMed] [Google Scholar]
  • 48.Pacher P, Csordas P, Schneider T, Hajnoczky G. Quantification of calcium signal transmission from sarco-endoplasmic reticulum to the mitochondria. J Physiol. 2000;529(Pt 3):553–564. doi: 10.1111/j.1469-7793.2000.00553.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Rizzuto R, Duchen MR, Pozzan T. Flirting in little space: the ER/mitochondria Ca2+ liaison. Sci STKE. 2004;2004:re1. doi: 10.1126/stke.2152004re1. [DOI] [PubMed] [Google Scholar]
  • 50.Langer GA, Peskoff A. Calcium concentration and movement in the diadic cleft space of the cardiac ventricular cell. Biophys J. 1996;70:1169–1182. doi: 10.1016/S0006-3495(96)79677-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Favaron M, Bernardi P. Tissue-specific modulation of the mitochondrial calcium uniporter by magnesium ions. FEBS Lett. 1985;183:260–264. doi: 10.1016/0014-5793(85)80789-4. [DOI] [PubMed] [Google Scholar]
  • 52.Litsky ML, Pfeiffer DR. Regulation of the mitochondrial Ca2+ uniporter by external adenine nucleotides: the uniporter behaves like a gated channel which is regulated by nucleotides and divalent cations. Biochemistry. 1997;36:7071–7080. doi: 10.1021/bi970180y. [DOI] [PubMed] [Google Scholar]
  • 53.Rustenbeck I, Eggers G, Reiter H, Munster W, Lenzen S. Polyamine modulation of mitochondrial calcium transport. I. Stimulatory and inhibitory effects of aliphatic polyamines, aminoglucosides and other polyamine analogues on mitochondrial calcium uptake. Biochem Pharmacol. 1998;56:977–985. doi: 10.1016/s0006-2952(98)00232-9. [DOI] [PubMed] [Google Scholar]
  • 54.Paucek P, Jaburek M. Kinetics and ion specificity of Na(+)/Ca(2+) exchange mediated by the reconstituted beef heart mitochondrial Na(+)/Ca(2+) antiporter. Biochim Biophys Acta. 2004;1659:83–91. doi: 10.1016/j.bbabio.2004.03.019. [DOI] [PubMed] [Google Scholar]
  • 55.Duchen MR, McGuinness O, Brown LA, Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res. 1993;27:1790–1794. doi: 10.1093/cvr/27.10.1790. [DOI] [PubMed] [Google Scholar]
  • 56.Palty R, Silverman WF, Hershfinkel M, Caporale T, Sensi SL, Parnis J, Nolte C, Fishman D, Shoshan-Barmatz V, Herrmann S, Khananshvili D, Sekler I. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc Natl Acad Sci U S A. 2010;107:436–441. doi: 10.1073/pnas.0908099107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Michels G, Khan IF, Endres-Becker J, Rottlaender D, Herzig S, Ruhparwar A, Wahlers T, Hoppe UC. Regulation of the human cardiac mitochondrial Ca2+ uptake by 2 different voltage-gated Ca2+ channels. Circulation. 2009;119:2435–2443. doi: 10.1161/CIRCULATIONAHA.108.835389. [DOI] [PubMed] [Google Scholar]
  • 58.Cox DA, Matlib MA. A role for the mitochondrial Na(+)-Ca2+ exchanger in the regulation of oxidative phosphorylation in isolated heart mitochondria. J Biol Chem. 1993;268:938–947. [PubMed] [Google Scholar]
  • 59.Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res. 2003;60:617–625. doi: 10.1016/j.cardiores.2003.09.025. [DOI] [PubMed] [Google Scholar]
  • 60.Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G, Sweeney HL, Robbins J, Molkentin JD. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med. 2008;14:442–447. doi: 10.1038/nm1736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Irwin WA, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L, Braghetta P, Columbaro M, Volpin D, Bressan GM, Bernardi P, Bonaldo P. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet. 2003;35:367–371. doi: 10.1038/ng1270. [DOI] [PubMed] [Google Scholar]
  • 62.Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med. 2008;14:1097–1105. doi: 10.1038/nm.1868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Griffiths EJ, Halestrap AP. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol. 1993;25:1461–1469. doi: 10.1006/jmcc.1993.1162. [DOI] [PubMed] [Google Scholar]
  • 64.Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, Robbins J, Molkentin JD. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 2005;434:658–662. doi: 10.1038/nature03434. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES